Travere Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC TVTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

808,189

Value ($000)

30,881

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	30,881	0.0%	808,189	12/31/2025
2025 Q3	11/10/2025	20,276	0.0%	848,356	9/30/2025
2025 Q2	8/12/2025	11,415	0.0%	771,296	6/30/2025
2025 Q1	9/15/2025	12,267	0.0%	684,543	3/31/2025
2024 Q4	2/6/2025	11,525	0.0%	661,603	12/31/2024
2024 Q3	11/12/2024	7,938	0.0%	567,409	9/30/2024
2024 Q2	8/12/2024	4,674	0.0%	568,593	6/30/2024
2024 Q1	5/9/2024	4,283	0.0%	555,472	3/31/2024
2023 Q4	2/6/2024	4,850	0.0%	539,487	12/31/2023
2023 Q3	11/8/2023	5,059	0.0%	565,919	9/30/2023
2023 Q2	8/10/2023	8,300	0.0%	540,353	6/30/2023
2023 Q1	5/12/2023	11,297	0.0%	502,330	3/31/2023
2022 Q4	2/13/2023	9,739	0.0%	463,111	12/31/2022
2022 Q3	11/14/2022	11,405	0.0%	462,842	9/30/2022
2022 Q2	8/15/2022	11,392	0.0%	470,147	6/30/2022
2022 Q1	5/13/2022	12,161	0.0%	471,880	3/31/2022
2021 Q4	2/11/2022	14,227	0.0%	458,320	12/31/2021
2021 Q3	11/16/2021	11,250	0.0%	463,879	9/30/2021
2021 Q2	8/16/2021	9,340	0.0%	640,115	6/30/2021
2021 Q1	5/17/2021	16,871	0.0%	675,650	3/31/2021
2020 Q4	2/16/2021	15,217	0.0%	558,310	12/31/2020